Millipore Corp licenses novel stem cell technology from Boston University School of Medicine.

Boston University and Millipore Corp announced a licensing agreement for a highly efficient method for creating induced Pluripotent Stem (iPS) cells derived from mouse fibroblasts by using a single virus vector instead of multiple viruses in the reprogramming process. The vector has been licensed to Millipore for nonhuman research reagent use and is expected to be made commercially available later in 2009. The powerful laboratory tool was created in Dec 2008 by a Boston University School of Medicine research team and represents a significant step toward the application of embryonic stem cell-like cells for clinical purposes such as the regeneration of organs damaged by inherited or …